ARV's in our lives[swiss].indd - Treatment Action Campaign
ARV's in our lives[swiss].indd - Treatment Action Campaign
ARV's in our lives[swiss].indd - Treatment Action Campaign
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Ask y<strong>our</strong> doctor or pharmacist for anti-nausea and diarrhoea medications when you first start therapy<br />
if you need them. If these medications aren’t effective, ask y<strong>our</strong> cl<strong>in</strong>ic for stronger or more effective<br />
medic<strong>in</strong>es.<br />
More serious side effects<br />
Liver toxicity: Nevirap<strong>in</strong>e, Efavirenz<br />
‘My first comb<strong>in</strong>ation was Nevirap<strong>in</strong>e and Combivir (AZT + 3TC)…Then I found out one day that<br />
my liver was not cop<strong>in</strong>g with the comb<strong>in</strong>ation, <strong>in</strong> particular the Nevirap<strong>in</strong>e. So it was stopped<br />
and they were do<strong>in</strong>g liver tests and everyth<strong>in</strong>g. While they were do<strong>in</strong>g<br />
that I had to change the regimen to Kaletra and Combivir. It was quite<br />
difficult because I wasn’t sure what was go<strong>in</strong>g on and the doctors<br />
were try<strong>in</strong>g to expla<strong>in</strong> but I th<strong>in</strong>k I was too anxious to take it all <strong>in</strong>.<br />
But I was talk<strong>in</strong>g to a friend of m<strong>in</strong>e a lot and then after I changed,<br />
Kaletra worked well with me and the whole comb<strong>in</strong>ation was good.’<br />
Prudence Mabele<br />
Although liver toxicity with Nevirap<strong>in</strong>e (or less commonly Efavirenz)<br />
does not happen to everyone who takes Nevirap<strong>in</strong>e, it can be very<br />
serious and life-threaten<strong>in</strong>g if it does occur. Less than 5% people<br />
have to change treatment for this reason, but because nevirap<strong>in</strong>e is<br />
<strong>in</strong>cluded <strong>in</strong> FDCs it is very important to know about these symptoms. If<br />
you have a rash with Nevirap<strong>in</strong>e, it is important that you have a blood<br />
test to check whether y<strong>our</strong> liver is be<strong>in</strong>g affected (called liver function<br />
tests or LFTs). LFTs check a range of liver enzymes. The one that will<br />
mostly be checked at government cl<strong>in</strong>ics/hospitals is ALT.<br />
If tests are not available, you can judge by symptoms, which <strong>in</strong>clude:<br />
• Feel<strong>in</strong>g sick (nausea) or be<strong>in</strong>g sick (vomit<strong>in</strong>g)<br />
• Poor appetite<br />
• If y<strong>our</strong> eyes or sk<strong>in</strong> look more yellow<br />
• Light-col<strong>our</strong>ed stools or dark-col<strong>our</strong>ed ur<strong>in</strong>e<br />
• Tenderness or swell<strong>in</strong>g <strong>in</strong> y<strong>our</strong> liver – y<strong>our</strong> liver is just below y<strong>our</strong> ribs on the right side of y<strong>our</strong><br />
body.<br />
If you have any of these symptoms, you should contact y<strong>our</strong> doctor immediately. Liver toxicity usually<br />
occurs <strong>in</strong> the first six weeks of treatment, but can also occur later. If you also have hepatitis then<br />
the risk of liver toxicity is much higher, and another choice of drug, other than Nevirap<strong>in</strong>e, would be<br />
more appropriate.<br />
Rash: Nevirap<strong>in</strong>e, Efavirenz<br />
About 10–15% of people who use Nevirap<strong>in</strong>e or Efavirenz get a low-level rash that is not serious,<br />
and about 5% people discont<strong>in</strong>ue the drug because of this. However, 2–3% of people can be at risk<br />
of a much more serious rash, especially us<strong>in</strong>g Nevirap<strong>in</strong>e.<br />
63